Cardiac glycosides: Prerequisites for the development of new cardiotonic compounds-Reference-Cited by-同舟云学术

Cardiac glycosides: Prerequisites for the development of new cardiotonic compounds

Published:1977-06 Issue:6 Volume:33 Page:697-703
ISSN:0014-4754
Container-title:Experientia
language:en
Short-container-title:Experientia

Author:

Güntert Th. W.,Linde H. H. A.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01944136.pdf

Reference66 articles.

1. W. Diederen and R. Kadatz, Ärztl. Forsch.24, 149 (1974)

2. M. A. Kimble and R. M. Elenbaas, J. Am. pharm. Ass.14, 362 (1974).

3. Cardiac Glycoside Therapy, in: Evaluations of Drug Interactions, p. 295. American Pharmaceutical Association, Washington, 1973. 1st ed.

4. G. K. Moe and A. E. Farah, in: The Pharmacological Basis of Therapeutics, 5th ed., p. 653, Ed. L. S. Goodman and A. Gilman, Macmillan Publ. Co. Inc, New York 1975.

5. K. Repke, Internist7, 418 (1966).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rh-Catalyzed cyclization of 2,3-allenoic acids in the presence of 2,3-allenols;Chemical Communications;2021

2. Are endogenous cardenolides controlled by atrial natriuretic peptide;Medical Hypotheses;2016-07

3. Quantitative Structure–Activity Relationship Studies on Na+,K+-ATPase Inhibitors;Chemical Reviews;2012-02-23

4. New Insights into the Regulation of Na+,K+-ATPase by Ouabain;International Review of Cell and Molecular Biology;2012

5. PHARMACOLOGICAL ASPECTS ON THE TREATMENT OF CHF;Acta Medica Scandinavica;2009-04-24